Results 21 to 30 of about 976,699 (171)

Preparation and Properties of Cyclodextrin Inclusion Complexes of Hyperoside

open access: yesMolecules, 2022
In order to improve the aqueous solubility and enhance the bioavailability of Hyperoside (Hyp), three inclusion complexes (ICs) of Hyp with 2-hydroxypropyl-β-cyclodextrin (2H-β-CD), β-cyclodextrin (β-CD), and methyl-β-cyclodextrin (M-β-CD) were prepared ...
Xinyu Zhang   +10 more
doaj   +1 more source

The thermodynamic study of p-methoxycinnamic acid inclusion complex formation, using β-cyclodextrin and hydroxypropyl-β-cyclodextrin [PDF]

open access: yes, 2021
Objectives: Cyclodextrin’s ability to form an inclusion complex with a guest molecule is a function of two factors. The first is steric and depends on the relative size of cyclodextrin cavity to the guest molecule, while the second is the thermodynamic ...
Dewi Isadiartuti   +4 more
core   +1 more source

Preparation, Properties and Sustained-release Properties of Naringin-loaded Cyclodextrin-polysaccharide-based Gel Spheres

open access: yesShipin gongye ke-ji, 2023
In order to make naringin have better water solubility and sustained release performance, hydroxypropyl-β-cyclodextrin was used to have strong adhectogenic ability for naringenin.
Wenjuan ZHANG   +4 more
doaj   +1 more source

Inclusion complexes and self-assembled cyclodextrin aggregates for increasing the solubility of benzimidazoles

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2019
Albendazole and fenbendazole are imidazole derivatives that exhibit broad spectrum activity against parasites, but the low solubility of these drugs considerably reduces their effectiveness. Complexation of albendazole and fenbendazole with cyclodextrins
Leticia Norma Carpentieri Rodrigues   +4 more
doaj   +1 more source

Enhanced Stability and Bioactivity of Natural Anticancer Topoisomerase I Inhibitors through Cyclodextrin Complexation

open access: yesPharmaceutics, 2021
The use of cyclodextrins as drug nano-carrier systems for drug delivery is gaining importance in the pharmaceutical industry due to the interesting pharmacokinetic properties of the resulting inclusion complexes.
Víctor González-Ruiz   +9 more
doaj   +1 more source

The Application of Microwave Heating Methods in Pharmaceutical Formulations [PDF]

open access: yes
This study investigated the potential application of formulating pharmaceutical products using microwave heating methods alongside associated analytical investigations.
Bedford, Susan
core   +3 more sources

Nasal powders of quercetin-β-cyclodextrin derivatives complexes with mannitol/lecithin microparticles for Nose-to-Brain delivery: In vitro and ex vivo evaluation [PDF]

open access: yes, 2021
Quercetin, a flavonoid with possible neuroprotective action has been recently suggested for the early-stage treatment of Alzheimer's disease. The low solubility and extended first pass effect render quercetin unsuitable for oral administration ...
Kostantini C.   +35 more
core   +2 more sources

INCLUSION COMPLEXES OF NICARDIPINE - HCl FOR ORAL ADMINISTRATION [PDF]

open access: yesBulletin of Pharmaceutical Sciences. Assiut University, 2005
Inclusion complexes of nicardipine HCl (NIC) with β-cyclodextrin (β-CD) and hydroxypropyl-β-cyclodextrin (HP-β-CD) were prepared using different methods: coevaporation, kneading and co-precipitation.
G. Atia   +5 more
doaj   +1 more source

The improved photostability of naproxen in the inclusion complex with 2-hydroxypropyl-β-cyclodextrin [PDF]

open access: yesHemijska Industrija, 2015
The aim of this work was the preparation of the inclusion complex of naproxen with 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) in order to improve the physical and chemical properties of naproxen.
Ilić-Stojanović Snežana S.   +6 more
doaj   +1 more source

Hyperglycosylated LAMP1 is regulated by 2-hydroxypropyl-β-cyclodextrin treatment.

open access: yes, 2020
A. LAMP1 and β-tubulin Western blot of total cerebellar extract from 7-week-old Npc1+/+ and Npc1−/− mice treated with either 2-hydroxypropyl-β-cyclodextrin (HPβCD) or the vehicle control (PBS) every 3 days starting at 3 weeks of age. B.
Antony Cougnoux (8198772)   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy